Yahoo Web Search

Search results

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 2 hours ago

      Gilead Sciences, a biotech company focused on treatments for cancer and HIV, isn’t pitching itself as an obesity-drug developer. But that hasn’t stopped...

    • Heard on the Street Recap: Cool Down

      Heard on the Street Recap: Cool Down

      The Wall Street Journal· 49 minutes ago

      U.S. markets got a splash of cold water on a hot day. The S&P 500 and Nasdaq Composite both closed in the red on Thursday following a break from trading...